Manufacturers of pharmaceutical goods are required to identify all products with a 2D data matrix code and add tamper-evidence labelling. A much less forgiving verifier of data than the human eye, scanners operate on strict binary principles, which means even the slightest of cell corruption will result in rejection of the code. Bart Vansteenkiste, of Domino’s Global Life Sciences Sector, considers EU requirements and serialisation tactics.